
    
      AIM: To evaluate the effectiveness of Pulmozyme(dornase alfa) in decreasing post-operative
      sinusitis symptoms in patients with cystic fibrosis (CF)

      PROCEDURES: 20 patients with CF will be randomized to receive either Pulmozyme or placebo via
      nasal inhalation daily for 12 months. Consent will be obtained following surgery and
      treatment will begin 1 week post-operatively.

      Monitoring will include examination and recording of adverse effects and follow up weekly for
      one month and then at 2.5, 6, 9 and 12 months.

      Outcome measures will include ciliary function testing, pulmonary function testing, sinus
      questionnaires and CT scan.
    
  